Le MPP dans les médias

Dans le monde entier, des publications de référence ont salué le travail du Medicines Patent Pool. Nous vous proposons ci-dessous une sélection d’articles, d’interviews données par des membres de notre équipe et de déclarations de gouvernements, d’organisations internationales et de représentants de la société civile sur les événements-clés qui ont marqué l’action du MPP.

Selection d’articles sur le MPP:


21 juillet 2017, La Tribune
VIH : plus de la moitié des malades ont désormais accès à un traitement

24 mai 2017, IP Watch
Beyond The Obvious – Direct And Indirect Territorial Coverage Of MPP/ViiV Voluntary License For Dolutegravir

23 mars 2017, The Lancet
The uphill battle to find new TB treatments

26 janvier 2017, Voice of America
Interview of MPP’s general counsel about implications of new TB licence for Africa


28 novembre 2016, Reuters
Mylan signs sub-license agreement with the Medicines Patent Pool to produce and market DAKLINZA tablets to 112 countries

19 septembre 2016, Le Temps
Les Objectifs de développement durables sont une chance pour les entreprises suisses

5 octobre 2016, TB Online
Medicines Patent Pool announces MedsPaL: its new Medicines Patents & Licences Database

20 juin 2016, The New York Times
New strategies to fight AIDS – Letter to the editor from MPP’s Executive Director

16 juin 2016, EFPIA Blog
Voluntary Patent Pooling: Encouraging Rapid Scale-Up of Medicines for Resource-Limited Countries

01 avril 2016, Generics Bulletin
Medicines Patent Pool has potential for wider scope


18 December 2015, Health24
New agreement could help end ARV stock outs

03 December 2015, PharmaBiz
The Medicines Patent Pool inks pact with the University of Liverpool to develop HIV nanomedicines

23 November 2015, Bloomberg
Bristol-Myers Lets Low-Income Countries Copy Hepatitis C Pills 

Fall issue, Global Health and Diplomacy
Global Innovative Financing for the Next Decade –  Greg Perry and Philippe Douste-Blazy

01 July 2015, The Times of India
MPP doubles its generic partners, adds more domestic drug firms

25 February 2015, Voice of America
Generic Form of Pediatric HIV Drug OK’d

24 February 2015, Reuters
Merck places children’s HIV drug in shared non-profit patent pool

24 February 2015,  The Wall Street Journal – Pharmalot
Pharmalot, Pharmalittle: We’re Reading About Novartis, Lilly, Merck and Lots More!!

24 February 2015, Devex
New deal allows generics makers license to sell HIV drug


01 December 2014, Reuters
AbbVie adds children’s AIDS drugs to shared patent pool

24 July 2014, Intellectual Property Watch:
New Medicines Patent Pool-Gilead Agreement For New HIV Drug In 112 Countries

18 July 2014, The Hindu:
Medicines Patent Pool inks pact with 7 firms for anti-AIDS drugs

17 June 2014, The Washington Post:
Trying to produce drugs appropriate for children with HIV

17 June 2014, Voice of America News
Radio interview with Greg Perry on Africa News Today (listen to 22:30 min)

19 May 2014. Intellectual Property Watch:
New Initiative To Address Lack Of Paediatric-Specific HIV Treatments

24 April 2014, Intellectual Property Watch:
One Year On At The Medicines Patent Pool: Interview With Greg Perry

01 April 2014, Reuters
GSK’s ViiV unit adds new HIV drug to AIDS patent pool

16 January 2014,  Journal of Public Health Policy
A quiet revolution in global public health: The World Health Organization’s Prequalification of Medicines Programme


2013 »

2012 »

31 July 2012, The Economic Times: Hetero Labs to produce Gilead’s HIV drugs, through Medicines Patent Pool

“The Obama administration should do all that it can to promote the Medicines Patent Pool, a bold initiative to bring down prices of HIV medicines.”
Rep Henry Waxman (D, California), op-ed in Politico, 25 July 2012.

25 July 2012, Politico: More work needs to be done on HIV

9 March 2012, Huffington Post: Can Patent Pools Get More AIDS Drugs to Patients?

1 March 2012, Economic Times of India: Big pharma companies must allow generic firms to sell cheap HIV drugs to poor nations

24 February 2012, Intellectual Property Watch: The Pulse of IP in International Pharma Today

The Medicines Patent Pool has given an additional kick to companies to look at what they could improve. And following the creation of the Pool, companies have been signing more licence agreements, with more products, and to more countries.”
Peter Beyer, senior advisor in the Department of Public Health, Innovation, and Intellectual Property at the World Health Organization, in Intellectual Property Watch, 24 February 2012

2011 »

13 October 2011, Nature Biotechnology: Gilead donates patents for generics

11 October 2011, Reuters: Aurobindo uses patent pool for generic AIDS drugs

22 July 2011, SCRIP Intelligence: ViiV’s licensing talks with Medicines Patent Pool progressing towards a deal

21 July 2011, The New York Times: Sharing Patents to Wipe Out AIDS

21 July 2011, Intellectual Property Watch Inside Views: Corporate Self-Interest And Strategic Choices: Gilead Licenses To Medicines Patent Pool

13 July 2011, Nature News: First drug company to dive into the HIV patent pool may help others take the plunge

13 July 2011, Financial Times: Gilead agrees to ease HIV patents

12 July 2011, Intellectual Property Watch: Medicines Patent Pool Boosts HIV Drug Prospects With First Licence

12 July 2011, New York Times: Company Agrees to Share AIDS and Hepatitis Drugs With Patent Pool

8 June 2011, Intellectual Property Watch:   Drug Access Issues In Spotlight At UN High-Level Meeting On HIV, WIPO Event

14 February 2011, Spicy IP: Medicines Patent Pool in talks with Big Pharma

10 February 2011, The Guardian:
Big Pharma shows willingness to pool HIV and Aids drug patents

…the determined bunch of people who have got the patent pool for AIDS drugs up and running are not only quietly working away, but getting results”
– Sarah Boseley, The Guardian, 10 February 2011

21 January 2011, Scrip Intelligence:
Big pharma “needs to play ball” after Washington backs AIDS patent pool
[subscription required]

20 January 2011, Pharmalot:
US Tells the WHO to Support a Patent Pool

2010 »

2009 »

21 December 2009, British Medical Journal: New HIV drug patent pool “offers hope to millions”

15 December 2009, Forbes:
AIDS in Africa – Progress On AIDS Plan

15 December 2009, Reuters: Sida – vers la mise en commun de brevets de médicaments pour les pays pauvres

15 December 2009, The Guardian: Unitaid approves patent pool to reduce cost of HIV drugs

10 July 2009, Intellectual Property Watch:
How to Avert the Coming Drug Access Crisis

21 April 2009, British Medical Journal: Patent pools: an idea whose time has come 

This page is also available in: Anglais, Espagnol